MRC/Yabao Link Indicates Growing China Capabilities
This article was originally published in PharmAsia News
Executive Summary
The decision by MRC Technology, a UK-based independent medical research charity, to link with China's Yabao Pharmaceutical to develop and commercialize novel drugs against a neurodegenerative disorder target indicates the growing capabilities and attractions of such Chinese partners.